AMLo Biosciences
David Macdonald has served in CEO and COO roles for over 25 years, most recently as the CEO at First Light Diagnostics, and formerly as a Division President, COO and Vice President at Quest Diagnostics. He has raised over USD $160 million privately in both equity and debt financings and he has led a series of companies through successful exits. He is a result-oriented, decisive leader with biotech industry expertise in a wide variety of medical diagnostic systems, molecular diagnostics, personalized medicine, pharma collaboration, medical devices, research products, and laboratory services. He has an extensive successful track record in M&A integration, fundraising, strategic planning, and business plan execution in complex life science companies, large and small, public, and private.
David has been an invited speaker at a variety of industry events and has served on several industry Advisory Boards and Boards of Directors. He holds a BSBA degree in Management and Finance from Northeastern University in Boston and an MBA from Babson College, Massachusetts, with a focus on Marketing and Entrepreneurship.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
AMLo Biosciences
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.